N-3 Fatty Acids. Antithromboxane Activity. Effects on Redox Status of Blood Cells
N-3 fatty acids are polyunsaturated ones that all derive from linolenic acid (18:3n-3) in animals. Together with linoleic acid (18:2n-6), that cannot be synthesized in animals, 18:3n-3 is considered as an essential fatty acid, especially in being the precursor of docosahexaenoic acid (DHA or 22:6n-3), the main polyunsaturated fatty acid (PUFA) of the cerebrovascular system (Salem, 1989). A great interest in n-3 fatty acids also consists in their ability to slow down the arachidonic acid cascade in blood and vascular cells, resulting in a potential prevention of cardiovascular diseases (Leaf & Weber, 1988). The present article will focus on the antithromboxane activity of n-3 fatty acids from marine oil and on their effects as prooxidant/antioxidant molecules.
KeywordsArachidonic Acid Human Platelet Arachidonic Acid Cascade Prostaglandin Endoperoxide Phospholipid Transfer Protein
Unable to display preview. Download preview PDF.
- Baidassare J.J., Tarver A.P., Henderson P.A., Mackin W.N., Sahagan b. and Fisher G.J. Reconstitution of thromboxane A2 receptor-stimulated phosphoinositide hydrolysis in isolated platelet membranes: involvement of phosphoinositide-specific phospholipase C-b and GTP-binding protein Gq. Biochem J., 1993, 291: 235–240.Google Scholar
- Croset M. and Lagarde M. In vitro incorporation and metabolism of eicosapentaenoic and docosahexaenoic acids in human platelets. Effects on aggregation. Thromb. Haemost, 1986, 56: 57–62.Google Scholar
- Douady D., Guerbette F., Grosbois m. and Kader J.C. Purification of a basic phospholipid transfer protein from maize seads using a two-step chromatographic procedure. Physiol. Veg., 1985, 232: 373–380.Google Scholar
- Lefer A.M. Eicosanoids as mediators of ischemia and shock. Fed. Froc, 1985, 44: 275–280.Google Scholar
- Moncada S. and Vane J.R. The role of prostacyclin in vascular tissue. Fed. Proa, 1979, 38: 66–71.Google Scholar
- Parent CA., Lagarde M., Venton D.L. and Le Breton G.C. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact and solubilized platelet membranes. J. Biol. Chem., 1992, 67: 6541–6547.Google Scholar
- Salem N. Omega-3 fatty acids: molecular and biochemical aspects. In: New Protective Roles for Selected Nutrients. Alan R. Liss, Inc., 1989, 109-228.Google Scholar
- Samuelsson B., Hamberg M., Malmsten C. and Svensson J. The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation. In: Adv. Thrombox. Res. Edited by B. Samuelsson and R. Paoletti, Raven Press N.Y 2, 1976, 737–746.Google Scholar
- Smith W.L. Prostanoid biosynthesis and mechanisms of action. Am. J. Physiol., 1992, 263: 181–191.Google Scholar
- Sprecher H. Biochemistry of essential fatty acids. Progr. Lipid Res., 1981, 20: 12–22.Google Scholar
- Swann P.G., Parent C.A., Croset M., Fonlupt P., Lagarde M., Venton D.L. and Le Breton G.C. Enrichment of platelet phospholipids with eicosapentaenoie acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function. J. Biol. Chem., 1990, 265: 21692–21697.PubMedGoogle Scholar